CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS BCR/ABL mRNA and the P210 BCR/ABL Protein Are Downmodulated by Interferon-a in Chronic Myeloid Leukemia Patients